Patricia L. Allen

Insider Reports History

Location
Waltham, MA
Signature
By: /s/ Chase Jayasekera, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Patricia L. Allen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zenas BioPharma, Inc. Director Common Stock 19,860 $523,509 $26.36 13 Feb 2026 Direct
Deciphera Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 $0 $10.58 11 Jun 2024 Direct
Zenas BioPharma, Inc. Director Stock Option (Right to Buy) 18,500 10 Jun 2025 Direct
YUMANITY THERAPEUTICS, INC. Director Stock Option (Right to Buy) 14,800 02 Jun 2021 Direct

Insider Reports Filed by Patricia L. Allen